DocMorris AG (CHIX:DOCMZ) FFO


CHIX:DOCMZ DocMorris AG CHIX:DOCMZ
67 GF Score
Price CHF7.92
GF Value CHF10.54
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is DocMorris AG FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:DOCMZ
67GF Score
DocMorris AG CHIX:DOCMZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DocMorris AG (CHIX:DOCMZ) Overvalued in 2026?

Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued. The current stock price of CHF7.92 is trading 24.9% below its estimated GF Value™ of CHF10.54. GuruFocus considers DocMorris AG to be Modestly Undervalued.

Key valuation signals for CHIX:DOCMZ:

  • FFO:
  • GF Value™: CHF10.54 vs. price of CHF7.92 (24.9% below fair value)
  • GF Score™: 67/100 with 8 warning signs

No single metric tells the full story. See the CHIX:DOCMZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DocMorris AG Business Description

Address Walzmuhlestrasse 49, Frauenfeld, CHE, 8500
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
67GF Score

Get the complete analysis for CHIX:DOCMZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF7.92
Price
CHF10.54
GF Value